265 related articles for article (PubMed ID: 18800069)
1. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.
Grillon C; Chavis C; Covington MF; Pine DS
Neuropsychopharmacology; 2009 Mar; 34(4):964-71. PubMed ID: 18800069
[TBL] [Abstract][Full Text] [Related]
2. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study.
Grillon C; Levenson J; Pine DS
Neuropsychopharmacology; 2007 Jan; 32(1):225-31. PubMed ID: 16971899
[TBL] [Abstract][Full Text] [Related]
3. Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.
Grillon C; Heller R; Hirschhorn E; Kling MA; Pine DS; Schulkin J; Vythilingam M
Biol Psychiatry; 2011 Mar; 69(6):549-55. PubMed ID: 21277566
[TBL] [Abstract][Full Text] [Related]
4. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
[TBL] [Abstract][Full Text] [Related]
5. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
Grillon C; Hale E; Lieberman L; Davis A; Pine DS; Ernst M
Neuropsychopharmacology; 2015 Mar; 40(5):1064-71. PubMed ID: 25430779
[TBL] [Abstract][Full Text] [Related]
6. Acute escitalopram but not contextual conditioning exerts a stronger "anxiogenic" effect in rats with high baseline "anxiety" in the acoustic startle paradigm.
Pettersson R; Näslund J; Nilsson S; Eriksson E; Hagsäter SM
Psychopharmacology (Berl); 2015 Apr; 232(8):1461-9. PubMed ID: 25417552
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepines have no effect on fear-potentiated startle in humans.
Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
[TBL] [Abstract][Full Text] [Related]
8. Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis?
Robinson OJ; Overstreet C; Allen PS; Pine DS; Grillon C
Neuropsychopharmacology; 2012 Jul; 37(8):1963-71. PubMed ID: 22491355
[TBL] [Abstract][Full Text] [Related]
9. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.
Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J
Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242
[TBL] [Abstract][Full Text] [Related]
10. Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology.
Grillon C
Biol Psychiatry; 2002 Nov; 52(10):958-75. PubMed ID: 12437937
[TBL] [Abstract][Full Text] [Related]
11. Measuring anxious responses to predictable and unpredictable threat in children and adolescents.
Schmitz A; Merikangas K; Swendsen H; Cui L; Heaton L; Grillon C
J Exp Child Psychol; 2011 Oct; 110(2):159-70. PubMed ID: 21440905
[TBL] [Abstract][Full Text] [Related]
12. A single dose of citalopram increases fear recognition in healthy subjects.
Browning M; Reid C; Cowen PJ; Goodwin GM; Harmer CJ
J Psychopharmacol; 2007 Sep; 21(7):684-90. PubMed ID: 17259206
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
Ayers L; Agostini A; Schulkin J; Rosen JB
Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
[TBL] [Abstract][Full Text] [Related]
14. The impact of cue learning, trait anxiety and genetic variation in the serotonin 1A receptor on contextual fear.
Baas JM; Heitland I
Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):506-14. PubMed ID: 25448266
[TBL] [Abstract][Full Text] [Related]
15. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.
Harmer CJ; Shelley NC; Cowen PJ; Goodwin GM
Am J Psychiatry; 2004 Jul; 161(7):1256-63. PubMed ID: 15229059
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.
Harmer CJ; Mackay CE; Reid CB; Cowen PJ; Goodwin GM
Biol Psychiatry; 2006 May; 59(9):816-20. PubMed ID: 16460693
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man.
Bitsios P; Philpott A; Langley RW; Bradshaw CM; Szabadi E
J Psychopharmacol; 1999; 13(3):226-34. PubMed ID: 10512076
[TBL] [Abstract][Full Text] [Related]
18. Fear-potentiated startle and light-enhanced startle models in drug discovery.
Groenink L; Bijlsma EY; Olivier B
Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration.
Ayers LW; Missig G; Schulkin J; Rosen JB
Neuropsychopharmacology; 2011 Nov; 36(12):2488-97. PubMed ID: 21796104
[TBL] [Abstract][Full Text] [Related]
20. Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex.
Grillon C; Ameli R; Woods SW; Merikangas K; Davis M
Psychophysiology; 1991 Sep; 28(5):588-95. PubMed ID: 1758934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
